ARase Therapeutics

Preclinical-stage biotechnology company targeting DNA repair deficiencies in tumors for the treatment of breast, ovarian, pancreatic, lung, and prostate cancer.

Location
Boston, Massachusetts, USA
Investors
1
Categories
biotech, oncology, dna-repair, precision-medicine

Investors

NameLocationTypeStagesPortfolio
Portal InnovationsUSbiotech-focused-13